3rd Quarter - Report — AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION (2021)

Firm

AMERICAN OSTEOPATHIC ASSOCIATION

Client

AMERICAN OSTEOPATHIC ASSOCIATION

Income

—

Expenses

$99,501

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

US HOuse of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: White House Office; Government Accountability Office (GAO); SENATE; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Health Issues HCR

US House of Representatives, HHS, HRSA, White House Office, CDC, CMS, FDA, GAO, OMB, EOP

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); Government Accountability Office (GAO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

US House of Representatives, US Senate, CMS, EOP, HHS, MedPAC, White House Office

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Government Accountability Office (GAO); White House Office; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP)

Budget/Appropriations BUD

US House of Representatives, US Senate, HHS, HRSA

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); White House Office; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); SENATE

Insurance INS

US House of Representatives, US Senate, EOP, HHS, CMS

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Education EDU

US House of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); White House Office; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Government Accountability Office (GAO); Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Medical/Disease Research/Clinical Labs MED

US House of Representatives, US Senate, HHS, HRSA, AHRQ

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); White House Office; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); SENATE

Torts TOR

US House of Representatives, US Senate

Lobbyist	Covered position, as disclosed
MARK LUKASZEWSKI	Associate Director, Congressional Affairs
DAVID PUGACH	Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA	Sr. Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); White House Office; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.